Lupin recalls blood pressure drug from US

09 Aug 2011 Evaluate

Drug firm Lupin is recalling one batch of Losartan Potassium Tablets, used in treating high blood pressure, from the US market for exceeding permissible impurity level.  According to the US Food and Drug Administration (USFDA) in its enforcement report, Indian firm was recalling a batch of 34,368 bottlesas the drug did not meet specification for impurities at the nine-month stability station. The batch, which is being recalled, was due to expire in July next year. The company produces the drug at its Goa facility. The recall falls under the FDA's class II category which means that the use of the drug may cause temporary or medically reversible adverse health consequences, but unlikely to have serious adverse health consequences.crackcrack

Lupin Share Price

2069.95 26.65 (1.30%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.